These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7275339)

  • 21. Permeability of heparinized hydrophilic polymer (H-RSD): application to semipermeable membrane for microencapsulation of activated charcoal.
    Mori Y; Nagaoka S; Tanzawa H; Kikuchi T; Yamada Y; Hagiwara M; Idezuki Y
    J Biomed Mater Res; 1982 Jan; 16(1):17-30. PubMed ID: 7056759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hemoperfusion with coated and uncoated charcoal on human blood in vitro.
    Ott NT; Kohnle W; Scheck R; Konstantin P; Franz HE
    J Dial; 1979; 3(4):291-308. PubMed ID: 263952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies of hemoperfusion devices. I. In vitro clearance characteristics.
    Cooney DO; Infantolino W; Kane R
    Biomater Med Devices Artif Organs; 1978; 6(3):199-213. PubMed ID: 728514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silicone as coating material for hemoperfusion.
    Otsubo O; Nomura M; Watanabe T; Takai N; Noguchi Y
    Trans Am Soc Artif Intern Organs; 1983; 29():480-4. PubMed ID: 6673272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro assessment of the removal of phenols by ACAC hemoperfusion.
    Kaziuka EN; Chang TM
    Int J Artif Organs; 1979 Jul; 2(4):215-21. PubMed ID: 457306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coating membranes for a sorbent-based artificial liver: adsorption characteristics.
    de Koning HW; Chamuleau RA; Bantjes A
    Artif Organs; 1982 Aug; 6(3):280-7. PubMed ID: 7181728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances of adsorbents for hemoperfusion in China.
    Yu YT; Chen CZ
    Biomater Artif Cells Artif Organs; 1990; 18(4):499-505. PubMed ID: 2285812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of polyamide coatings for selective adsorption control on activated charcoal.
    Wicks SR; Richardson NE; Meakin BJ
    J Biomed Mater Res; 1980 Nov; 14(6):743-51. PubMed ID: 7052206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of Uremic Toxins by Functionalized Graphene-Based Composite Beads for Direct Hemoperfusion.
    Tyagi A; Ng YW; Tamtaji M; Abidi IH; Li J; Rehman F; Hossain MD; Cai Y; Liu Z; Galligan PR; Luo S; Zhang K; Luo Z
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):5955-5965. PubMed ID: 33497185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new combined enzyme-charcoal system adsorption on charcoal followed by polymer coating.
    Pişkin K; Chang TM
    Int J Artif Organs; 1980 Nov; 3(6):344-6. PubMed ID: 7461872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hemoperfusion over uncoated and polymer-coated charcoal on hematological levels in the conscious rat.
    Ryan CJ; Courtney JM
    Int J Artif Organs; 1982 Jul; 5(4):249-56. PubMed ID: 7118287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The possibility of improving biocompatibility by removing anaphylatoxins from the circuit of blood-perfused artificial organs.
    Oka T
    ASAIO Trans; 1989; 35(4):778-83. PubMed ID: 2611046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging technologies in extracorporeal treatment: focus on adsorption.
    Mikhalovsky SV
    Perfusion; 2003 Mar; 18 Suppl 1():47-54. PubMed ID: 12708765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coating charcoal with polyacrylate-polymethacrylate copolymer for haemoperfusion. III: The effect of the coat thickness on the adsorptioncapacity of the coated charcoal and its adsorptivity to small and middle size molecules.
    el-Kheshen S; Zia H; Badawi A; Needham TE; Luzzi LA
    J Microencapsul; 1995; 12(5):505-14. PubMed ID: 8544094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of polyetherurethane sheet embedded with powdered charcoal for use in hemoperfusion.
    Kawanishi H; Nishiki M; Sugiyama M; Cho T; Tsuchiya T; Ezaki H
    Artif Organs; 1984 May; 8(2):167-73. PubMed ID: 6732544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACAC (albumin-collodion coated activated charcoal) hemoperfusion: in-vitro removal and clearance of theophylline.
    Espinosa-Meléndez E; Chang TM
    J Dial; 1980; 4(1):21-9. PubMed ID: 7410675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with prolonged combined hemoperfusion-hemodialysis treatment of severe poisoning.
    De Broe ME; Verpooten GA; Christiaens MA; Rutsaert RJ; Holvoet J; Nagler J; Heyndrickx A
    Artif Organs; 1981 Feb; 5(1):59-66. PubMed ID: 7247757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technical aspects of hemoperfusion.
    Piskin E
    Int J Artif Organs; 1986 Sep; 9(5):289-92. PubMed ID: 3781658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed matrix membranes: a new asset for blood purification therapies.
    Tijink MS; Kooman J; Wester M; Sun J; Saiful S; Joles JA; Borneman Z; Wessling M; Stamatialis DF
    Blood Purif; 2014; 37(1):1-3. PubMed ID: 24401819
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of a charcoal sorbent fiber with commercial charcoals for hemoperfusion.
    Gundermann KJ; Uhlhaas S; Grünn U; Olek K; Ukigusa M; Lie TS
    Artif Organs; 1983 May; 7(2):186-96. PubMed ID: 6870596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.